The stock market seems incredibly strong right now.

Wall Street headlines are celebrating daily.

Corporate profits are beating expectations at a rapid pace.

And the major market indexes are hovering near all-time highs.

If you only look at surface-level numbers, everything seems fine and dandy... But a closer inspection reveals a deeply split market.

Simply put, the rally we're seeing today is not healthy. It's highly concentrated and driven by speculative trading.

To show you what I mean, let's first look directly at the corporate fundamentals...

First-quarter earnings for 2026 were exceptionally strong. Businesses outperformed what analysts predicted just a few months ago by a whopping 9.2%.

As you can see below, that's the single strongest earnings beat since the post-pandemic boom of late 2021...

Over the past few years, earnings surprises averaged between 3% and 5%. The recent 9.2% blowout means businesses are managing higher costs better than expected...

Companies are making a lot of money.

This should be a clear buy signal, right? If profits are exceeding expectations at a five-year high, most stocks should be doing well. Standard financial logic says that stock prices follow profits.

But that's not what we're seeing today...

While the S&P 500 Index is near record highs, the current rally is very uneven. It's concentrated in a tiny group of stocks known as the "Retail Favorites." This basket, which is mainly composed of popular AI and tech names, has surged in value recently.

At the same time, individual retail trading volume has soared.

You can see this dynamic in the chart below... Trading volume recently rose to nearly 900 million shares from about 700 million shares. This spike lines up with the performance of the Retail Favorites stocks.

When retail volume spikes, these favorite stocks easily beat the S&P 500 Equal Weight Index, which treats all 500 companies equally. That's because retail traders typically don't buy boring, cash-flow-heavy businesses. They pile into popular momentum stocks.

And because the main S&P 500 is weighted by market cap and doesn't treat all companies equally, a massive surge in a few mega-cap stocks pulls the entire index up.

So the market strength we're seeing today is a bit misleading. It's not a broad rally across a majority of stocks. It's being driven by speculative retail traders pouring into a very small number of popular companies.

Another way to look at it, the percentage of S&P 500 stocks at 20-day highs is unusually low for a bull market...

For real strength behind the rally, we'd want to see closer to 55% of stocks trading at 20-day highs.

This market split leaves individual investors with a clear choice...

You can chase the crowd and buy into a few expensive momentum stocks... Or you can look for stocks where cash flows are stable and valuations remain reasonable.

History shows that speculative retail booms eventually slow down. When retail traders pull back or run out of money to keep buying, artificial price supports disappear. This causes fast and sharp corrections in the market's favorite stocks.

On the other hand, high-moat businesses that stay out of the retail spotlight tend to keep growing over time. They can compound cash flows no matter what the rest of the market is doing.

Don't let the 9.2% earnings surprise mislead you into buying overvalued assets. Look past index headlines.

Remember, your job is to build long-term wealth that lasts across generations.

So let the crowd trade the speculative names and risk losing their shirts. Instead, focus on keeping your capital parked in stable businesses with clear pricing power, strong balance sheets, and a history of steady growth.

These types of companies are exactly what we look for in Retirement Millionaire. As part of the team, I work alongside Doc Eifrig to uncover high-quality businesses built to survive market cycles.

We recommend companies that can earn you reliable gains in the long term, not whatever hot, overvalued stock everyone's already piling into.

To learn more about Retirement Millionaire and how it can help you, click here.

What We're Reading...

Here's to our health, wealth, and a great retirement,

Jeff Havenstein
May 20, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top